Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital
• 100% clinical success rate: zero complications linked to robot at day 0 and day 30
• R-One™ obtained 86% technical success rate
Rouen and Rennes, France, October 19, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment of cardiovascular diseases, today announces the results of its ‘CARE’ clinical trial focusing on robotic carotid stenting (1). This study is the first phase in an ambitious research program launched in July…